Company profile for VivaVision

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

VivaVision is a clinical stage pharmaceutical company focused on best-in-class and first-in-class therapies for ocular diseases .Since its establishment, the company has focused on the research and development of internationally leading innovative drugs for the treatment of ophthalmic diseases, and is committed to providing better and better treatment options for millions of patients with ophthalmic diseases. The company has a...
VivaVision is a clinical stage pharmaceutical company focused on best-in-class and first-in-class therapies for ocular diseases .Since its establishment, the company has focused on the research and development of internationally leading innovative drugs for the treatment of ophthalmic diseases, and is committed to providing better and better treatment options for millions of patients with ophthalmic diseases. The company has a world-class ophthalmology team and has established a leading product research and development pipeline.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
Building 6, Lane 917, Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Sh...
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/vivavision-announces-positive-comments-from-fda-for-the-type-c-meeting-regarding-vvn461ld-for-post-operative-infalmmation--agreeing-the-phase-2-trial-to-be-served-as-one-of-the-two-pivotal-studies-302476201.html

PR NEWSWIRE
09 Jun 2025

https://www.prnewswire.com/news-releases/latest-updates-of-viva-biotechs-portfolio-companies-302345738.html

PR NEWSWIRE
08 Jan 2025

https://www.globenewswire.com/news-release/2024/12/04/2991736/0/en/VivaVision-Announces-Positive-Topline-Results-from-Phase-2-Trial-of-VVN461-for-Post-Operative-Inflammation-Following-Cataract-Surgery.html

GLOBENEWSWIRE
04 Dec 2024

https://www.prnewswire.com/news-releases/vivavision-announces-positive-topline-results-from-phase-2-trial-of-vvn461-for-post-operative-inflammation-following-cataract-surgery-302320734.html

PR NEWSWIRE
03 Dec 2024

https://www.clinicaltrialsarena.com/news/vivavisions-ophthalmic-meets-primary-endpoints/

CLINICAL TRIALS ARENA
05 Jun 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty